LGVN logo

Longeveron (LGVN) Company Overview

Profile

Full Name:

Longeveron Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 12, 2021

Indexes:

Not included

Description:

Longeveron (LGVN) is a biotechnology company focused on developing innovative therapies using stem cells. They aim to treat age-related and serious health conditions, such as heart disease and Alzheimer’s. Longeveron conducts clinical trials to test the safety and effectiveness of their treatments.

Key Details

Price

$1.51

Annual Revenue

$2.39 M(+237.38% YoY)

Annual EPS

-$2.62(-156.36% YoY)

Annual ROE

-111.59%

Beta

1.69

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 27, 2024

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Dec 5, 24 Roth MKM
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Nov 4, 24 HC Wainwright & Co.
Buy
Sep 4, 24 HC Wainwright & Co.
Buy
Aug 27, 24 Maxim Group
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jul 31, 24 HC Wainwright & Co.
Buy
Jul 29, 24 HC Wainwright & Co.
Buy
May 17, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Longeveron?
  • Does Longeveron pay dividends?
  • What sector is Longeveron in?
  • What industry is Longeveron in?
  • What country is Longeveron based in?
  • When did Longeveron go public?
  • Is Longeveron in the S&P 500?
  • Is Longeveron in the NASDAQ 100?
  • Is Longeveron in the Dow Jones?
  • When was Longeveron's last earnings report?
  • When does Longeveron report earnings?
  • Should I buy Longeveron stock now?

What is the ticker symbol for Longeveron?

The ticker symbol for Longeveron is NASDAQ:LGVN

Does Longeveron pay dividends?

No, Longeveron does not pay dividends

What sector is Longeveron in?

Longeveron is in the Healthcare sector

What industry is Longeveron in?

Longeveron is in the Biotechnology industry

What country is Longeveron based in?

Longeveron is headquartered in United States

When did Longeveron go public?

Longeveron's initial public offering (IPO) was on February 12, 2021

Is Longeveron in the S&P 500?

No, Longeveron is not included in the S&P 500 index

Is Longeveron in the NASDAQ 100?

No, Longeveron is not included in the NASDAQ 100 index

Is Longeveron in the Dow Jones?

No, Longeveron is not included in the Dow Jones index

When was Longeveron's last earnings report?

Longeveron's most recent earnings report was on Feb 28, 2025

When does Longeveron report earnings?

The next expected earnings date for Longeveron is May 14, 2025

Should I buy Longeveron stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions